PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2006 | 12 |
| 2007 | 41 |
| 2008 | 121 |
| 2009 | 52 |
| 2010 | 53 |
| 2011 | 29 |
| 2012 | 83 |
| 2013 | 34 |
| 2014 | 32 |
| 2015 | 24 |
| 2016 | 35 |
| 2017 | 26 |
| 2018 | 19 |
| 2019 | 16 |
| 2020 | 30 |
| 2021 | 26 |
| 2022 | 15 |
| 2023 | 15 |
| 2024 | 6 |
| 2025 | 4 |
| 2026 | 9 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"PPAR Res"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Serum Metabolomic Profiling Reveals Potential Mechanisms and Biomarkers of Seladelpar Treatment in Patients With Primary Biliary Cholangitis.
- Choi YJ, Schwab A, Lim J, Carlisle SM, McWherter CA, Johnson JD.
- PPAR Res. 2026 Sep 25;2026:2362528. doi: 10.1155/ppar/2362528.
- PMCID: PMC13613439
Choi YJ, et al.PPAR Res. 2026.PMCID: PMC13613439 -
RETRACTION: Synergistic Antiproliferative Effects of Combined γ-Tocotrienol and PPARγ Antagonist Treatment Are Mediated through PPARγ-Independent Mechanisms in Breast Cancer Cells.
- Research P.
- PPAR Res. 2026 Jul 14;2026:9797132. doi: 10.1155/ppar/9797132.
- PMCID: PMC13366493
-
- Retracts: PPAR Res. 2014;2014:439146. doi: 10.1155/2014/439146. PubMed Abstract
Research P.PPAR Res. 2026.PMCID: PMC13366493Retraction notice. -
Correction to "Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?".
- [No authors listed]
- PPAR Res. 2026 Jul 1;2026:9796467. doi: 10.1155/ppar/9796467.
- PMCID: PMC13323155
[No authors listed]PPAR Res. 2026.PMCID: PMC13323155 -
Latest Advances in Obesity Treatment by Regulating Adipocyte Thermogenesis.
- Nie T, Chen J, Wang Z, Mao L.
- PPAR Res. 2026 Jun 21;2026:1742256. doi: 10.1155/ppar/1742256.
- PMCID: PMC13284497
Nie T, et al.PPAR Res. 2026.PMCID: PMC13284497 -
Metabolic Reprogramming and Immune Metabolism in Sepsis: Targeting the PPAR Pathway for Personalized Therapeutic Approaches.
- Wu Z, Chen Y, Yin L, Zhu L, Ding F, Dai L.
- PPAR Res. 2026 May 9;2026:2166122. doi: 10.1155/ppar/2166122.
- PMCID: PMC13157310
Wu Z, et al.PPAR Res. 2026.PMCID: PMC13157310 -
Mediating Role of Muscle Mass in the Relationship Between Physical Activity and Bone Mass in Female University Students in China.
- Wang J, Zhang Z, Li S, Hu HY, Chen H, Zhang Z, Lu X, Yan Y.
- PPAR Res. 2026 Apr 3;2026:5484324. doi: 10.1155/ppar/5484324.
- PMCID: PMC13051863
Wang J, et al.PPAR Res. 2026.PMCID: PMC13051863 -
Correction to "Pemafibrate Pretreatment Attenuates Apoptosis and Autophagy During Hepatic Ischemia-Reperfusion Injury by Modulating JAK2/STAT3β/PPARα Pathway".
- [No authors listed]
- PPAR Res. 2026 Jan 31;2026:9841376. doi: 10.1155/ppar/9841376.
- PMCID: PMC12866985
[No authors listed]PPAR Res. 2026.PMCID: PMC12866985 -
The Mechanistic Role of PPARγ in Wound Healing.
- Wang Z, Jia K, Wang W, Du X, Wu Y, Wang J.
- PPAR Res. 2026 Jan 28;2026:2242856. doi: 10.1155/ppar/2242856.
- PMCID: PMC12866987
Wang Z, et al.PPAR Res. 2026.PMCID: PMC12866987 -
To Explore the Active Components, Targets, and Potential Effects of Emodin in the Treatment of Colorectal Cancer Based on Network Pharmacology.
- Chen L, Li J, Cheng Z, Jin F, Shi J, Weng L, He C, Wang L, Qiu Z.
- PPAR Res. 2025 Nov 12;2025:6547135. doi: 10.1155/ppar/6547135.
- PMCID: PMC12629705
Chen L, et al.PPAR Res. 2025.PMCID: PMC12629705 -
Single-Nuclei RNA Sequencing Shows the Engagement of PPAR-Delta Target Genes Primarily in Hepatocytes and Cholangiocytes by the Selective PPAR-Delta Agonist Seladelpar.
- Yamazaki T, Yang Y, Schöler D, Yukawa-Muto Y, Kouno T, Harberts A, Sakane S, Freund L, Hsu CL, Whisenant TC, Rosenthal SB, Kisseleva T, Cable EE, Schnabl B.
- PPAR Res. 2025 Oct 23;2025:2935230. doi: 10.1155/ppar/2935230.
- PMCID: PMC12575037
Yamazaki T, et al.PPAR Res. 2025.PMCID: PMC12575037